Norway · Delayed Price · Currency is NOK Komplett ASA Earnings Call Transcripts
Fiscal Year 2025
-
Q4 EBIT rose to NOK 102 million, up NOK 25 million year-over-year, with full-year EBIT improving by NOK 91 million. Gross margin and liquidity strengthened, but Swedish operations faced a NOK 535 million impairment. Supply chain risks and memory price hikes remain key uncertainties.
-
Q3 delivered a NOK 49 million year-over-year EBIT improvement, driven by margin gains, stable costs, and strong B2C performance, especially in Norway. Liquidity and working capital improved, while cost and efficiency measures are set to further boost profitability into 2025.
-
Stable sales and improved gross margin marked Q2, with strong B2C growth in Norway and ongoing restructuring. Inventory and costs rose due to expansion, but liquidity and leverage remain solid, with further deleveraging and cost savings expected in H2.
-
Revenue grew 3.8% year-over-year in Q1 2025, with stable gross margin and strong performance in Norway, offset by mixed results in Sweden due to brand repositioning. Strategic cost and restructuring measures are underway, with most benefits expected in the second half of 2025.
Fiscal Year 2024
-
Q4 delivered 3.1% revenue growth and stable margins amid intense competition, with strong Black Week sales and new product launches supporting demand. Liquidity and cost control improved, while cost reduction initiatives and store expansions progressed. Early 2025 outlook is optimistic, but market unpredictability remains.
-
Q3 saw a 3.1% year-over-year sales decline amid weak demand and intense competition, with negative NOK 46 million adjusted EBIT. Liquidity and working capital improved, while strategic initiatives and cost-saving measures progressed. Outlook is cautiously optimistic as market conditions and product cycles improve.
-
Sales declined year-over-year amid weak demand and strong competition, especially in Sweden, but cost reductions and improved liquidity strengthened the financial position. Margin pressure is expected to ease in H2, with new product launches and commercial initiatives supporting recovery.